The Company currently anticipates fiscal year 2025 consolidated net sales of approximately $925 million, ahead of its most recently issued guidance of approximately $920 million. Initial Fiscal Year ...
Greetings. Welcome to the USANA Health Sciences First Quarter Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the presentation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results